Literature DB >> 2186318

[Diabetes mellitus and breast cancer. A retrospective follow-up study].

P Unterburger1, A Sinop, W Noder, M R Berger, M Fink, L Edler, D Schmähl, H Ehrhart.   

Abstract

The influence of diabetes mellitus on the course of breast cancer was investigated retrospectively in 752 patients. Possible unfavourable prognostic factors like overweight, lipid disorders, age and menopausal status were considered as confounders in a Cochran-Mantel-Haensel analysis. There was no difference in primary tumor status and lymph node involvement between patients with diabetes mellitus and nondiabetic patients. Diabetic patients had more often overweight, lipid disorders and were older than nondiabetic patients. Metastatic disease was highly significant correlated with primary tumor status (p less than 10(-6)) lymph node involvement (p less than 10(-10)) and diabetes mellitus (p less than 10(-5)). Overweight, lipid disorders, age and menopausal status were not correlated with metastatic disease. A possible explanation of the correlation between diabetes mellitus and metastatic disease could be hyperinsulinism in type IIB diabetes. A type IIB diabetes in most of the patients included in this study is very plausible because of the correlation between overweight, lipid disorders, old age and diabetes mellitus. This type of diabetes is characterised by a relative resistence to insulin in the target tissues and a prolonged and exceeding insulin secretion. Experimental data demonstrate that insulin stimulates the growth of breast cancer cell in vivo and in vitro.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2186318     DOI: 10.1159/000216712

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  4 in total

1.  The impact of diabetes mellitus on breast cancer outcomes: a single center retrospective study.

Authors:  Swaroopa Yerrabothala; Hamid Shaaban; Gerardo Capo; Michael Maroules; Vincent A Debari
Journal:  Pathol Oncol Res       Date:  2013-07-06       Impact factor: 3.201

2.  Type 2 diabetes mellitus and prognosis in early stage breast cancer women.

Authors:  Muhammet Ali Kaplan; Zafer Pekkolay; Mehmet Kucukoner; Ali Inal; Zuhat Urakci; Hamza Ertugrul; Recai Akdogan; Ugur Firat; Ismail Yildiz; Abdurrahman Isikdogan
Journal:  Med Oncol       Date:  2011-11-15       Impact factor: 3.064

3.  Insulin glargine versus other types of basal insulin-clinical and tumor characteristics in patients with breast carcinoma.

Authors:  Nikola Besic; Nika Satej
Journal:  BMC Res Notes       Date:  2013-10-16

4.  Long-term use of metformin and the molecular subtype in invasive breast carcinoma patients - a retrospective study of clinical and tumor characteristics.

Authors:  Nikola Besic; Nika Satej; Ivica Ratosa; Andreja Gojkovic Horvat; Tanja Marinko; Barbara Gazic; Rok Petric
Journal:  BMC Cancer       Date:  2014-04-28       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.